Pre-earnings brief
Reports
Mon, Oct 26, 2026
Est. EPS
$0.00
Est. revenue
$650M
Implied move
±10.9%
EPS beat rate
25%
Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) that focuses on acquiring, developing, and managing properties for the life sciences and technology sectors. With a market cap of $8 billion, it plays a crucial role in providing specialized spaces for companies in healthcare and biotechnology, which are increasingly important in today's economy.
Last quarter
In Q2-2026, Alexandria reported an EPS of $1.73, exceeding estimates by 5.1%. The stock reacted positively, gaining 3.07% the following day.
Management promises and guidance
EPS beat streak
2Q
EPS beat rate
25%
Avg EPS surprise
-9.65%
Avg 1-day reaction
-0.53%
Analysts expect Alexandria to report stable revenues, but the lack of EPS growth guidance raises concerns. The market is watching closely for any signs of growth in leasing activity.
Bull case
If Alexandria can report higher-than-expected revenues and show strong demand for its properties, it could signal robust growth in the life sciences sector.
Bear case
Conversely, if the company reports lower revenues or occupancy rates, it may indicate challenges in attracting tenants, leading to a negative market reaction.
Key metrics to watch
EPS
$0.00Earnings per share is a key indicator of profitability and will help gauge how well the company is managing its costs and revenues.
Revenue
$650MRevenue figures will show how effectively the company is growing its business and attracting tenants in the competitive healthcare real estate market.
The print will turn on these.
Q1
What will the occupancy rate be for the upcoming quarter?
Occupancy rates are critical for REITs, as they directly impact revenue and profitability.
Q2
How much leasing activity has occurred in the last quarter?
Increased leasing activity can indicate strong demand for Alexandria's properties, which is vital for future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±9.4%
Why consensus could be wrong
The Street may be underestimating the potential for Alexandria to capitalize on increased demand for life sciences space, which could lead to higher-than-expected revenues.
Supporting evidence
The company has a strong track record of exceeding revenue expectations in previous quarters.
Options pricing suggests a significant move, indicating that traders are anticipating volatility.
Recent trends in the healthcare sector show increased investment and demand for specialized real estate.
Key risk
If leasing activity shows a significant uptick, it could challenge current revenue projections.
Pre-commit to what would confirm each case.
This quarter's performance is crucial as it reflects the company's ability to navigate the competitive healthcare real estate market.
Bull confirmed if
A revenue figure exceeding $673 million would confirm strong demand and growth potential.
Bear confirmed if
Revenue falling below $639 million would signal potential challenges in attracting tenants.
What the market is pricing for the move.
Implied Move
±10.89%
Historical Avg
±2.0%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±10.9% while ARE has averaged ±2.0% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
34.9%
Smart-money positioning from the most recent 13F filings.
Institutional
100.24%
of float
Insider
1.38%
of float
Holders
866
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
21,692,019 sh · $980.7M
12.45%
10.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Alexandria beats expectations, history suggests the stock could rise by around 3%, confirming strong demand in the healthcare sector.
In line / cautious
An in-line report may lead to a muted reaction, as investors await further guidance on future growth.
Miss
If the company misses expectations, history suggests a potential decline of about 0.58%, raising concerns about its leasing performance.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
NORGES BANK
16,437,663 sh · $743.1M
9.43%
-0.1%
Vanguard Portfolio Management LLC
14,001,369 sh · $633.0M
8.04%
1.1%
Vanguard Capital Management LLC
10,842,415 sh · $490.2M
6.22%
0.9%
State Street Corporation
10,596,116 sh · $479.1M
6.08%
-0.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
Recent Transactions
Traded Apr 14, 2026 · disclosed May 8, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.